Edwards Lifesciences Corporation (EW) stock analysis

EW · Edwards Lifesciences Corporation

Latest recorded price: USD 107.12

Model-estimated fair value: USD 31.74. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Medical Devices

At $107.12, EW trades 237.4% above the model's base-case value of $31.74. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $27.17 in the conservative case and $36.89 in the optimistic case, with a valuation confidence score of 45/100. About 75% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 4.1%, free cash flow margin 22.0%, ROIC 15.9%. The model does not flag any risk signals for this company.

Similar companies in Healthcare